Waters Co. (NYSE:WAT) Given Average Rating of “Hold” by Brokerages

Shares of Waters Co. (NYSE:WAT) have been given an average rating of “Hold” by the fifteen ratings firms that are presently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $210.54.

WAT has been the topic of several recent analyst reports. Barclays reduced their price target on shares of Waters from $218.00 to $210.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 24th. ValuEngine downgraded shares of Zumiez from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd. Bank of America raised shares of First Horizon National from an “underperform” rating to a “neutral” rating and set a $16.00 target price on the stock in a research report on Tuesday, July 16th. UBS Group raised their target price on shares of W. R. Berkley from $53.00 to $56.00 and gave the company a “sell” rating in a research report on Wednesday, April 24th. Finally, Zacks Investment Research downgraded shares of Horiba from a “hold” rating to a “sell” rating in a research report on Wednesday, May 22nd.

WAT stock traded down $1.09 during trading on Tuesday, hitting $213.72. The company had a trading volume of 560,161 shares, compared to its average volume of 589,720. The stock has a market cap of $14.85 billion, a price-to-earnings ratio of 25.78, a P/E/G ratio of 2.37 and a beta of 1.07. Waters has a 52-week low of $167.93 and a 52-week high of $255.21. The firm has a 50 day moving average of $211.58. The company has a debt-to-equity ratio of 1.15, a current ratio of 3.44 and a quick ratio of 2.89.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, April 23rd. The medical instruments supplier reported $1.60 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.73 by ($0.13). The company had revenue of $513.90 million during the quarter, compared to analysts’ expectations of $545.82 million. Waters had a return on equity of 39.64% and a net margin of 24.59%. The company’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.59 EPS. As a group, analysts anticipate that Waters will post 9.11 earnings per share for the current year.

Institutional investors have recently modified their holdings of the company. Commonwealth Equity Services LLC lifted its holdings in shares of Waters by 3.3% in the fourth quarter. Commonwealth Equity Services LLC now owns 3,280 shares of the medical instruments supplier’s stock valued at $618,000 after purchasing an additional 106 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Waters by 6.2% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,202 shares of the medical instruments supplier’s stock valued at $1,359,000 after purchasing an additional 420 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of Waters by 33.8% in the fourth quarter. Van ECK Associates Corp now owns 297 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 75 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Waters by 16.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 290,913 shares of the medical instruments supplier’s stock valued at $54,875,000 after purchasing an additional 41,782 shares in the last quarter. Finally, Stifel Financial Corp lifted its holdings in shares of Waters by 10.5% in the fourth quarter. Stifel Financial Corp now owns 3,658 shares of the medical instruments supplier’s stock valued at $689,000 after purchasing an additional 347 shares in the last quarter. 92.56% of the stock is currently owned by hedge funds and other institutional investors.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Article: Does a trade war provide a risk to the global economy?

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.